Literature DB >> 26122000

Microscopic Positive Margins in Differentiated Thyroid Cancer Is Not an Independent Predictor of Local Failure.

Laura Y Wang1,2, Ronald Ghossein2, Frank L Palmer1, Iain J Nixon1, R Michael Tuttle3, Ashok R Shaha1, Jatin P Shah1, Snehal G Patel1, Ian Ganly1.   

Abstract

BACKGROUND: In contrast to other head and neck cancers, the impact of histological thyroid specimen margin status in differentiated thyroid cancer (DTC) is not well understood. The aim of this study was to investigate the prognostic value of margin status on local recurrence in DTC.
METHOD: The records of 3664 consecutive patients treated surgically for DTC between 1986 and 2010 were identified from an institutional database. Patients with less than total thyroidectomy, unresectable or gross residual disease, or M1 disease at presentation and those with unknown pathological margin status were excluded from analysis. In total, 2616 patients were included in the study; 2348 patients (90%) had negative margins and 268 patients (10%) had positive margins. Microscopic positive margin status was defined as tumor present at the specimen's edge on pathological analysis. Patient, tumor, and treatment characteristics were compared by Pearson's chi-squared test. Local recurrence free survival (LRFS) was calculated for each group using the Kaplan Meier method.
RESULTS: The median age of the cohort was 48 years (range 7-91 years) and the median follow-up was 50 months (range 1-330 months). Age, sex, and histology types were similar between groups. As expected, patients who had positive margins were more likely to have larger tumors (p<0.001), extrathyroidal extension (ETE) (p<0.001), multicentric disease (p<0.001), or nodal disease (p<0.001) and were more likely to receive adjuvant radioactive iodine therapy (p<0.001) as well as external beam radiotherapy (p<0.001). The LRFS at 5 years for patients with positive margins status was slightly poorer compared with patients with negative margins (98.9% vs. 99.5%, p=0.018). Twelve patients developed local recurrence-8/2348 (0.34%) patients with negative margins and 4/263 (1.52%) patients with positive margins. Univariate predictors of LRFS were sex (p=0.006), gross ETE (<0.001), and positive margins (p=0.018). However, when controlling for presence of gross ETE on multivariate analysis, microscopic positive margin status was not an independent predictor of LRFS (p=0.193).
CONCLUSION: Patients with resectable, M0 disease that undergo total thyroidectomy have an excellent five year LRFS of 99.4%. Microscopic positive margin status was not a significant predictor for local failure after adjusting for ETE or pathological tumor (pT) stage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122000      PMCID: PMC4968280          DOI: 10.1089/thy.2015.0141

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

1.  Prognostic implications of microscopic involvement of surgical resection margin in patients with differentiated papillary thyroid cancer after high-dose radioactive iodine ablation.

Authors:  Chae Moon Hong; Byeong-Cheol Ahn; Ji Young Park; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee
Journal:  Ann Nucl Med       Date:  2012-02-08       Impact factor: 2.668

Review 2.  Medical management of thyroid cancer: a risk adapted approach.

Authors:  R Michael Tuttle; Rebecca Leboeuf; Ashok R Shaha
Journal:  J Surg Oncol       Date:  2008-06-15       Impact factor: 3.454

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 4.  Surgical margins in head and neck squamous cell carcinoma: what is 'close'?

Authors:  Matteo Alicandri-Ciufelli; Marco Bonali; Alessia Piccinini; Laura Marra; Angelo Ghidini; Elio Maria Cunsolo; Antonino Maiorana; Livio Presutti; Pier Franco Conte
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-28       Impact factor: 2.503

5.  Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years.

Authors:  J Brierley; R Tsang; T Panzarella; N Bana
Journal:  Clin Endocrinol (Oxf)       Date:  2005-10       Impact factor: 3.478

6.  Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.

Authors:  Sin-Ming Chow; Stephen Yau; Chung-Kong Kwan; Patricia C M Poon; Stephen C K Law
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

Review 7.  Update to the College of American Pathologists reporting on thyroid carcinomas.

Authors:  Ronald Ghossein
Journal:  Head Neck Pathol       Date:  2009-02-28

8.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989.

Authors:  I D Hay; E J Bergstralh; J R Goellner; J R Ebersold; C S Grant
Journal:  Surgery       Date:  1993-12       Impact factor: 3.982

9.  Differentiated thyroid cancer with extrathyroidal extension: prognosis and the role of external beam radiotherapy.

Authors:  Michael A Sia; Richard W Tsang; Tony Panzarella; James D Brierley
Journal:  J Thyroid Res       Date:  2010-05-06
  9 in total
  15 in total

Review 1.  Crucial parameters in thyroid carcinoma reporting - challenges, controversies and clinical implications.

Authors:  Bin Xu; Ronald A Ghossein
Journal:  Histopathology       Date:  2018-01       Impact factor: 5.087

Review 2.  Microscopic positive surgical margins in thyroid carcinoma: a proposal for thyroid oncology teams.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Iain J Nixon; Ricard Simo
Journal:  Langenbecks Arch Surg       Date:  2021-02-08       Impact factor: 3.445

Review 3.  Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Nancy D Perrier; James D Brierley; R Michael Tuttle
Journal:  CA Cancer J Clin       Date:  2017-11-01       Impact factor: 508.702

4.  Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?

Authors:  Victoria Harries; Laura Y Wang; Marlena McGill; Bin Xu; R Michael Tuttle; Richard J Wong; Ashok R Shaha; Jatin P Shah; Ronald Ghossein; Snehal G Patel; Ian Ganly
Journal:  Surgery       Date:  2019-09-09       Impact factor: 3.982

Review 5.  [Hemithyroidectomy or total thyroidectomy for low-risk papillary thyroid cancer? : Surgical criteria for primary and secondary choice of treatment in an interdisciplinary treatment concept].

Authors:  H Dralle; F Weber; A Machens; T Brandenburg; K W Schmid; D Führer-Sakel
Journal:  Chirurgie (Heidelb)       Date:  2022-09-19

6.  Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor.

Authors:  M G Castagna; R Forleo; F Maino; N Fralassi; F Barbato; P Palmitesta; T Pilli; M Capezzone; L Brilli; C Ciuoli; S Cantara; C Formichi; F Pacini
Journal:  J Endocrinol Invest       Date:  2018-02-22       Impact factor: 4.256

7.  Surgery in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  J J Homer; M J Fardy
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

Review 8.  Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.

Authors:  Ronald Ghossein; Justine A Barletta; Martin Bullock; Sarah J Johnson; Kennichi Kakudo; Alfred K Lam; Mufaddal T Moonim; David N Poller; Giovanni Tallini; R Michael Tuttle; Bin Xu; Anthony J Gill
Journal:  Hum Pathol       Date:  2020-09-10       Impact factor: 3.466

9.  Preoperative Factors Associated with Extrathyroidal Extension in Papillary Thyroid Cancer.

Authors:  Chi-Yu Kuo; Po-Sheng Yang; Ming-Nan Chien; Shih-Ping Cheng
Journal:  Eur Thyroid J       Date:  2020-04-14

10.  Positive Surgical Margins in the 10 Most Common Solid Cancers.

Authors:  Ryan K Orosco; Viridiana J Tapia; Joseph A Califano; Bryan Clary; Ezra E W Cohen; Christopher Kane; Scott M Lippman; Karen Messer; Alfredo Molinolo; James D Murphy; John Pang; Assuntina Sacco; Kathryn R Tringale; Anne Wallace; Quyen T Nguyen
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.